Filing Details
- Accession Number:
- 0001213900-21-021365
- Form Type:
- 4
- Zero Holdings:
- No
- Publication Time:
- 2021-04-13 15:10:13
- Reporting Period:
- 2021-04-09
- Accepted Time:
- 2021-04-13 15:10:13
- SEC Url:
- Form 4 Filing
Issuer
Cik | Name | Symbol | Sector (SIC) | IRS No |
---|---|---|---|---|
1828989 | Panacea Acquisition Corp. Ii | PANA | () | 4 |
Insiders
Cik | Name | Reported Address | Insider Title | Director | Officer | Large Shareholder | Other |
---|---|---|---|---|---|---|---|
1454385 | Oleg Nodelman | C/O Panacea Acquisition Corp. Ii, 357 Tehama Street, Floor 3 San Francisco, CA 94103 | Ceo And Chairman Of The Board | Yes | Yes | No | No |
1567938 | Ecor1 Capital Fund, L.p. | C/O Panacea Acquisition Corp. Ii, 357 Tehama Street, Floor 3 San Francisco, CA 94103 | Yes | No | Yes | No | |
1587114 | Ecor1 Capital, Llc | C/O Panacea Acquisition Corp. Ii, 357 Tehama Street, Floor 3 San Francisco, CA 94103 | Yes | No | Yes | No | |
1598292 | Ecor1 Capital Fund Qualified, L.p. | C/O Panacea Acquisition Corp. Ii, 357 Tehama Street, Floor 3 San Francisco, CA 94103 | Yes | No | Yes | No | |
1778011 | Ecor1 Venture Opportunity Fund, Lp | C/O Panacea Acquisition Corp. Ii, 357 Tehama Street, Floor 3 San Francisco, CA 94103 | Yes | No | Yes | No | |
1816370 | Biotech Opportunity Gp, Llc | C/O Panacea Acquisition Corp. Ii, 357 Tehama Street, Floor 3 San Francisco, CA 94103 | Yes | No | Yes | No | |
1842055 | Ecor1 Panacea Holdings Ii, Llc | C/O Panacea Acquisition Corp. Ii, 357 Tehama Street, Floor 3 San Francisco, CA 94103 | Yes | No | Yes | No |
Reported Non-Derivative Transactions
Sec. Name | Acquisiton - Disposition | Date | Amount | Price | Remaning Holdings | Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|---|---|---|---|---|---|
Class A Ordinary Shares | Acquisiton | 2021-04-09 | 545,000 | $10.00 | 545,000 | No | 4 | P | Direct |
Equity Swap Involved | Form Type | Code | Nature of Ownership | Explanation |
---|---|---|---|---|
No | 4 | P | Direct |
Footnotes
- The reporting owner, EcoR1 Panacea Holdings II, LLC (the "Sponsor"), in whose name the securities reported herein are held, is managed by its managing members, EcoR1 Capital Fund, L.P., EcoR1 Capital Fund Qualified, L.P. and EcoR1 Venture Opportunity Fund, L.P. The general partner of EcoR1 Capital Fund, L.P. and EcoR1 Capital Fund Qualified, L.P. is EcoR1 Capital, LLC and the general partner of EcoR1 Venture Opportunity Fund, L.P. is Biotech Opportunity GP, LLC (together with EcoR1 Capital, LLC, the "General Partners"). Oleg Nodelman is the manager of each of the General Partners. Each of the Reporting Persons may be deemed a beneficial owner of shares held by the Sponsor but each (other than the Sponsor) disclaims beneficial ownership of any such shares except to the extent of its respective pecuniary interest therein.